Review of Sleep Disorders

Medical Clinics of North America

Volumn 93, Issue 2, 2009, Pages 407-425

  Panossian, Lori A ^a   Avidan, Alon Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Circadian rhythm; Classification; Insomnia; Management; Parasomnia; Sleep apnea

Indexed keywords

ALCOHOL; AMITRIPTYLINE; BENZODIAZEPINE DERIVATIVE; CAFFEINE; CLOMIPRAMINE; CLONAZEPAM; CORTICOSTEROID DERIVATIVE; DEXAMPHETAMINE; DIPHENHYDRAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; DOXEPIN; ESTAZOLAM; ESZOPICLONE; FLUOXETINE; MELATONIN; METHYLPHENIDATE; MODAFINIL; OREXIN; OXYBATE SODIUM; RAMELTEON; SELEGILINE; TEMAZEPAM; TRAZODONE; TRIAZOLAM; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE; ZALEPLON; ZOLPIDEM; ZOLPIDEM TARTRATE;

ACTIMETRY; AGE DISTRIBUTION; ANTICHOLINERGIC EFFECT; ANXIETY DISORDER; BEDTIME DOSAGE; BEHAVIOR DISORDER; CATAPLEXY; CIRCADIAN RHYTHM SLEEP DISORDER; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; DAYTIME SOMNOLENCE; DEPRESSION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; ELECTROENCEPHALOGRAPHY; ELECTROOCULOGRAPHY; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; HYPERCHOLESTEROLEMIA; INSOMNIA; JET LAG; LIGHT EXPOSURE; LOW DRUG DOSE; MORBIDITY; NARCOLEPSY; NIGHTMARE; OBESITY; PARASOMNIA; PHYSICAL EXAMINATION; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PRIORITY JOURNAL; REM SLEEP; RESTLESS LEGS SYNDROME; REVIEW; SEDATION; SEX DIFFERENCE; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP STAGE; SLEEP THERAPY; SNORING; SOMATOFORM DISORDER; UNPLEASANT DREAM;

COGNITIVE THERAPY; HUMANS; HYPNOTICS AND SEDATIVES; PHYSICAL EXAMINATION; POLYSOMNOGRAPHY; SLEEP DISORDERS;

EID: 61449239168     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2008.09.001     Document Type: Review

References (100)

1. Thorpy M.J. Approach to the patient with a sleep complaint. Semin Neurol 24 3 (2004) 225-235
2. Breslau N., Roth T., Rosenthal L., et al. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry 39 6 (1996) 411-418
3. Lockley S.W., Barger L.K., Ayas N.T., et al. Effects of health care provider work hours and sleep deprivation on safety and performance. Jt Comm J Qual Patient Saf 33 11 Suppl (2007) 7-18
4. Copinschi G. Metabolic and endocrine effects of sleep deprivation. Essent Psychopharmacol 6 6 (2005) 341-347
5. American Academy of Sleep Medicine, A. The international classification of sleep disorders. In: Sateia M. (Ed). Diagnostic and coding manual. 2nd edition (2005), American Academy of Sleep Medicine, Westchester (IL) 1-297
6. Hailey D., Tran K., Dales R., et al. Recommendations and supporting evidence in guidelines for referral of patients to sleep laboratories. Sleep Med Rev 10 4 (2006) 287-299
7. Bae C., and Avidan A. Evaluation and testing of the sleepy patient. In: Smith H.R., Comella C.L., and Birgit H. (Eds). Sleep medicine (2008), Cambridge University Press, Cambridge (UK) 25-46
8. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14 6 (1991) 540-545
9. Boeve B.F., Silber M.H., and Ferman T.J. REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 17 3 (2004) 146-157
10. Schenck C.H., Bundlie S.R., and Mahowald M.W. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 46 2 (1996) 388-393
11. Littner M.R., Kushida C., Wise M., et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 28 1 (2005) 113-121
12. Kushida C.A., Morgenthaler T.I., Littner M.R., et al. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 28 4 (2005) 499-521
13. Silber M. Insomnia. Continuum Lifelong Learning Neurol 13 3 (2007) 85-100
14. Benca R.M. Insomnia. In: Avidan A.Y., and Zee P.C. (Eds). Handbook of sleep medicine (2006), Lippincott Williams & Wilkins, Philadelphia 36-69
15. National Institutes of Health State of the Science Conference statement on manifestations and management of chronic insomnia in adults, June 13-15, 2005. Sleep 28 9 (2005) 1049-1057
16. Ohayon M.M. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 6 2 (2002) 97-111
17. Ohayon M.M., and Roth T. What are the contributing factors for insomnia in the general population?. J Psychosom Res 51 6 (2001) 745-755
18. Ohayon M.M., Zulley J., Guilleminault C., et al. How age and daytime activities are related to insomnia in the general population: consequences for older people. J Am Geriatr Soc 49 4 (2001) 360-366
19. Smith M.T., Klick B., Kozachik S., et al. Sleep onset insomnia symptoms during hospitalization for major burn injury predict chronic pain. Pain 138 3 (2008) 497-506
20. Stiefel F., and Stagno D. Management of insomnia in patients with chronic pain conditions. CNS Drugs 18 5 (2004) 285-296
21. Gottlieb D.J., Punjabi N.M., Newman A.B., et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 165 8 (2005) 863-867
22. Phillips B., and Mannino D.M. Do insomnia complaints cause hypertension or cardiovascular disease?. J Clin Sleep Med 3 5 (2007) 489-494
23. Sallinen M., Holm J., Hirvonen K., et al. Recovery of cognitive performance from sleep debt: do a short rest pause and a single recovery night help?. Chronobiol Int 25 2 (2008) 279-296
24. Pj H. Primary insomnia. 2003.
25. Fetveit A., Straand J., and Bjorvatn B. Sleep disturbances in an arctic population: The Tromso Study. BMC Health Serv Res 8 (2008) 117-125
26. Nofzinger E.A., Buysse D.J., Germain A., et al. Functional neuroimaging evidence for hyperarousal in insomnia. Am J Psychiatry 161 11 (2004) 2126-2128
27. Morin C.M., Rodrigue S., and Ivers H. Role of stress, arousal, and coping skills in primary insomnia. Psychosom Med 65 2 (2003) 259-267
28. Durmer J., and Chervin R. Pediatric sleep medicine. Continuum Lifelong Learning Neurol 13 3 (2007) 153-200
29. Rybarczyk B., Stepanski E., Fogg L., et al. A placebo-controlled test of cognitive-behavioral therapy for comorbid insomnia in older adults. J Consult Clin Psychol 73 6 (2005) 1164-1174
30. Sivertsen B., Omvik S., Pallesen S., et al. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. JAMA 295 24 (2006) 2851-2858
31. Irwin M.R., Cole J.C., and Nicassio P.M. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age. Health Psychol 25 1 (2006) 3-14
32. Edinger J.D., and Means M.K. Cognitive-behavioral therapy for primary insomnia. Clin Psychol Rev 25 5 (2005) 539-558
33. Wu R., Bao J., Zhang C., et al. Comparison of sleep condition and sleep-related psychological activity after cognitive-behavior and pharmacological therapy for chronic insomnia. Psychother Psychosom 75 4 (2006) 220-228
34. Edinger J.D., Wohlgemuth W.K., Radtke R.A., et al. Dose-response effects of cognitive-behavioral insomnia therapy: a randomized clinical trial. Sleep 30 2 (2007) 203-212
35. Lieberman J.A. Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care. Prim Care Companion J Clin Psychiatry 9 1 (2007) 25-31
36. Zammit G., Erman M., Wang-Weigand S., et al. Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia. J Clin Sleep Med 3 5 (2007) 495-504
37. Buscemi N., Vandermeer B., Hooton N., et al. The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. J Gen Intern Med 20 12 (2005) 1151-1158
38. Buscemi N., Vandermeer B., Hooton N., et al. Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ 332 7538 (2006) 385-393
39. Banno K., and Kryger M.H. Sleep apnea: clinical investigations in humans. Sleep Med 8 4 (2007) 400-426
40. White D.P. Sleep apnea. Proc Am Thorac Soc 3 1 (2006) 124-128
41. Tabba M.K., and Johnson J.C. Obstructive sleep apnea: a practical review. Mo Med 103 5 (2006) 509-513
42. Chan A., and Kushida C. Sleep-disordered breathing. Continuum Lifelong Learning Neurol 13 3 (2007) 139-152
43. Sewell-Scheuermann S., and Phillips B. Sleep-disordered breathing. In: Avidan A.Y., and Zee P.C. (Eds). Handbook of sleep medicine (2006), Lippincott Williams & Wilkins, Philadelphia 13-35
44. Young T., Palta M., Dempsey J., et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328 17 (1993) 1230-1235
45. Tishler P.V., Larkin E.K., Schluchter M.D., et al. Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing. JAMA 289 17 (2003) 2230-2237
46. Hudgel D.W. Mechanisms of obstructive sleep apnea. Chest 101 2 (1992) 541-549
47. Mehra R., Stone K.L., Blackwell T., et al. Prevalence and correlates of sleep-disordered breathing in older men: osteoporotic fractures in men sleep study. J Am Geriatr Soc 55 9 (2007) 1356-1364
48. Alchanatis M., Zias N., Deligiorgis N., et al. Comparison of cognitive performance among different age groups in patients with obstructive sleep apnea. Sleep Breath 12 1 (2007) 17-24
49. Weaver T.E., and Chasens E.R. Continuous positive airway pressure treatment for sleep apnea in older adults. Sleep Med Rev 11 2 (2007) 99-111
50. Guilleminault C., and Abad V.C. Obstructive sleep apnea syndromes. Med Clin North Am 88 (2004) 611-630
51. Lavie L. Sleep-disordered breathing and cerebrovascular disease: a mechanistic approach. Neurol Clin 23 4 (2005) 1059-1075
52. Weaver T.E., and Grunstein R.R. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc 5 2 (2008) 173-178
53. Sundaram S., Bridgman S.A., Lim J., et al. Surgery for obstructive sleep apnoea. Cochrane Database Syst Rev 4 (2005) CD001004
54. Sher A., and Goldberg A. Upper airway surgery for obstructive sleep apnea. Sleep apnea pathogenesis diagnosis and treatment. In: Pack A. (Ed). Sleep apnea (2002), Marcel Dekker, New York 575-605
55. Pillar G., Schnall R., Peled R., et al. Surgical treatment of sleep apnea syndrome. Isr J Med Sci 32 9 (1996) 710-715
56. Thorpy M.J. Narcolepsy. Continuum Lifelong Learning Neurol 13 3 (2007) 101-114
57. Dauvilliers Y., Arnulf I., and Mignot E. Narcolepsy with cataplexy. Lancet 369 9560 (2007) 499-511
58. Hoban T., and Chervin R. Hypersomnia and narcolepsy. In: Avidan A., and Zee P.C. (Eds). Handbook of sleep medicine (2006), Lippincott Williams & Wilkins, Philadelphia 70-97
59. The international classification of sleep disorders pocket version: diagnostic & coding manual. 2nd editon (2006), American Academy of Sleep Medicine, West (IL)
60. Black III J.L. Narcolepsy: a review of evidence for autoimmune diathesis. Int Rev Psychiatry 17 6 (2005) 461-469
61. Broughton R.J., Fleming J.A., George C.A., et al. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology 49 2 (1997) 444-451
62. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group. Neurology 54 5 (2000) 1166-1175
63. Thorpy M. Therapeutic advances in narcolepsy. Sleep Med 8 4 (2007) 427-440
64. Wise M.S., Arand D.L., Auger R.R., et al. Treatment of narcolepsy and other hypersomnias of central origin. Sleep 30 12 (2007) 1712-1727
65. Okawa M., and Uchiyama M. Circadian rhythm sleep disorders: characteristics and entrainment pathology in delayed sleep phase and non-24-h sleep-wake syndrome. Sleep Med Rev 11 6 (2007) 485-496
66. Lu B., Manthena P., and Zee P.C. Circadian rhythm sleep disorders. In: Avidan A., and Zee P.C. (Eds). Handbook of sleep medicine (2006), Lippincott Williams & Wilkins, Philadelphia 137-164
67. Reid K.J., and Zee P.C. Circadian rhythm disorders. Semin Neurol 24 3 (2004) 315-325
68. Morgenthaler T.I., Lee-Chiong T., Alessi C., et al. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report. Sleep 30 11 (2007) 1445-1459
69. Avidan A. Motor disorders of sleep and parasomnias. In: Avidan A., and Zee P.C. (Eds). Handbook of sleep medicine (2006), Lippincott Williams & Wilkins, Philadelphia 98-136
70. Vaughn B.V., and D'Cruz O.N. Parasomnias and other nocturnal events. American Academy of Neurology Continuum: lifelong learning in neurology. Sleep Disorders 13 3 (2007) 225-247
71. Zaiwalla Z. Parasomnias. Clin Med 5 2 (2005) 109-112
72. Lee-Chiong Jr. T.L. Parasomnias and other sleep-related movement disorders. Prim Care 32 2 (2005) 415-434
73. Ferini-Strambi L., Fantini M.L., Zucconi M., et al. REM sleep behaviour disorder. Neurol Sci 26 Suppl 3 (2005) s186-s192
74. Mahowald M.W., Bornemann M.C., and Schenck C.H. Parasomnias. Semin Neurol 24 3 (2004) 283-292
75. Farid M., and Kushida C.A. Non-rapid eye movement parasomnias. Curr Treat Options Neurol 6 4 (2004) 331-337
76. Leo G. Parasomnias. WMJ 102 1 (2003) 32-35
77. Sheldon S.H. Parasomnias in childhood. Pediatr Clin North Am 51 1 (2004) 69-88 vi
78. Ferini-Strambi L., and Zucconi M. REM sleep behavior disorder. Clin Neurophysiol 111 Suppl 2 (2000) S136-S140
79. Matsurnoto M., Mutoh F., Naoe H., et al. The effects of imipramine on REM sleep behavior disorder in 3 cases. Sleep Res 20A (1991) 351
80. Nash J.R., Wilson S.J., Potokar J.P., et al. Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism. Neurology 61 8 (2003) 1161
81. Stolz S.E., and Aldrich M.S. REM sleep behavior disorder associated with caffeine abuse. Sleep Res 20 (1991) 341
82. Boeve B.F., Silber M.H., and Ferman T.J. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med 4 4 (2003) 281-284
83. Boeve B. Melatonin for treatment of REM sleep behavior disorder: response in 8 patients. Sleep 24 Suppl (2001) A35
84. Ringman J.M., and Simmons J.H. Treatment of REM sleep behavior disorder with donepezil: a report of three cases. Neurology 55 6 (2000) 870-871
85. Bamford C.R. Carbamazepine in REM sleep behavior disorder. Sleep 16 1 (1993) 33-34
86. Walters A.S. Restless legs syndrome and periodic limb movements in sleep. American Academy of Neurology Continuum: lifelong learning in neurology. Sleep Disorders 13 3 (2007) 115-138
87. Trenkwalder C., Paulus W., and Walters A.S. The restless legs syndrome. Lancet Neurol 4 8 (2005) 465-475
88. Benes H., Walters A.S., Allen R.P., et al. Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics. Mov Disord 22 Suppl 18 (2007) S401-S408
89. Allen R.P., Picchietti D., Hening W.A., et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4 2 (2003) 101-119
90. Rama A.N., and Kushida C.A. Restless legs syndrome and periodic limb movement disorder. Med Clin North Am 88 3 (2004) 653-667 viii
91. Lesage S., and Hening W.A. The restless legs syndrome and periodic limb movement disorder: a review of management. Semin Neurol 24 3 (2004) 249-259
92. Winkelman J.W., Sethi K.D., Kushida C.A., et al. Efficacy and safety of pramipexole in restless legs syndrome. Neurology 67 6 (2006) 1034-1039
93. Littner M.R., Kushida C., Anderson W.M., et al. Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 27 3 (2004) 557-559
94. Lesage S., and Earley C.J. Restless legs syndrome. Curr Treat Options Neurol 6 3 (2004) 209-219
95. Hening W.A., Allen R.P., Earley C.J., et al. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 27 3 (2004) 560-583
96. Cheer S.M., Bang L.M., and Keating G.M. Ropinirole: for the treatment of restless legs syndrome. CNS Drugs 18 11 (2004) 747-754 [discussion 755-6]
97. Allen R., Becker P.M., Bogan R., et al. Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome. Sleep 27 5 (2004) 907-914
98. Adler C.H., Hauser R.A., Sethi K., et al. Ropinirole for restless legs syndrome: a placebo-controlled crossover trial. Neurology 62 8 (2004) 1405-1407
99. Wetter T.C., Winkelmann J., and Eisensehr I. Current treatment options for restless legs syndrome. Expert Opin Pharmacother 4 10 (2003) 1727-1738
100. Trenkwalder C., Hogl B., Benes H., et al. Augmentation in restless legs syndrome is associated with low ferritin. Sleep Med 9 5 (2007) 572-574